Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
rhTPO
Decitabine
Locations
1
China
ShengJing Hospital of China Medical University
Shenyang, Liaoning, China
Start Date
January 21, 2022
Primary Completion Date
January 21, 2024
Completion Date
January 21, 2026
Last Updated
May 19, 2022
NCT05564390
NCT03050268
NCT07320235
NCT06782542
NCT06439199
NCT05886049
Lead Sponsor
Huihan Wang
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions